Author: Arvin Arvin
finnCap Research Company Notes – 28 April 2020
Categories: NewsfinnCap Research Company Notes – 28 April 2020 ANGLE (AGL) : Corp Progress report since COVID-19 lockdown Key data ANGLE provided a positive update on business activities since the COVID-19 lockdown, confirming that both laboratories in the UK and Canada are operational and that progress is being made on multiple fronts despite the lockdown. ANGLE
finnCap Tech Chat | Checking the conditions
Categories: BlogfinnCap Tech Chat | Checking the conditions finnCap Tech Chat | Checking the conditions TA lot of us are now needing to cut hair as a month of lockdown is taking its toll. Unbelievably, if you trust your dexterity, you can now get a virtual haircut with an actual barber/hairdresser guiding you through what to
Global pharma and biotech’s fight against COVID-19
Categories: BlogGlobal pharma and biotech’s fight against COVID-19 Perhaps it’s time for some good news. First of all, just today biotherapeutics developer Avacta has announced its partnership with Cytiva, formerly known as GE Healthcare Life Sciences, to develop and manufacture a point-of-care (POC) rapid test to diagnose COVID-19 infection. Meanwhile, finnCap Group recently helped raise £14m
finnCap Research Company Notes – 15 April 2020
Categories: NewsfinnCap Research Company Notes – 15 April 2020 Revolution Bars Group (RBG) : COVID-19 and bank facility update Key data The group has issued a statement providing an update on the initiatives taken so far to manage the business through the COVID-19 crisis. The statement also confirms that subject to final documentation, its bank has
Health Matters: COVID-19 Testing – 9 April 2020
Categories: NewsHealth Matters: COVID-19 Testing – 9 April 2020 Weekly thoughts on the healthcare sector from finnCap’s life sciences analysts: Mark Brewer and Arshad Ahad source: finnCap, WHO source: finnCap, WHO Testing, testing, testing Antigen Testing Antibody Testing Follow us Ready to start a conversation?
finnCap Research Company Notes – 8 April 2020
Categories: NewsfinnCap Research Company Notes – 8 April 2020 Real Good Food (RGD) : Corp COVID-19 and trading update Key data The year-end trading update confirms that revenue and adjusted EBITDA were broadly in line with expectations, despite performance being affected in March due to COVID-19. The statement also confirms that the Board expects a material
New report: The AIM response to COVID-19
Categories: NewsNew report: The AIM response to COVID-19 finnCap’s Research Team has pulled together this latest report, charting the responses from AIM and quoted companies on how they’re dealing with COVID-19 and its long term impact. Raymond Greaves, Head of Research, finnCap Group, comments: “We look at three key areas: i) how are forecasts moving; ii)
finnCap Research Company Notes – 7 April 2020
Categories: NewsfinnCap Research Company Notes – 7 April 2020 Amino Technologies (AMO) : Corp Further contract win for 24i Key data Amino’s 24i division has announced a contract win with First Look Media, to power the new streaming video experience for the Topic platform. 24i will enable the launch and management of Topic across multiple platforms,
finnCap Tech Chat | March goes out like a lion, too
Categories: BlogfinnCap Tech Chat | March goes out like a lion, too Now I understand there is something called a lockdown occurring. It’s a very strange thing but having spent the last few weeks of March buried in prelims, Excel spreadsheets and Word documents, as reporting season comes to an end every April the Lesser-Spotted Equities
finnCap Research Company Notes – 31 March 2020
Categories: NewsfinnCap Research Company Notes – 31 March 2020 ANGLE (AGL) : Corp COVID-19 impact Key data ANGLE previously indicated that it expected to file a De Novo submission with the FDA for Parsortix, initially in metastatic breast cancer, and complete the enrolment of its 200-patient ovarian cancer verification study by the end of Q1 2020.
